Ta, new ASX data-ann out, much clearer/concise...
MITCI seems to be holding the ~50% rate, bit down from the previous 57%, but still >4 times improvement on Vervoy alone (11%), so BMS may still make a move, time will tell...
Either way, we're (LT holders) in a good place either way...
ML
Latest clinical trial results, page-7
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)